Tarceva is ranked 487,979 in the United States. 'Tarceva® (erlotinib) for Advanced Non-Small Cell Lung Cancer (NSCLC) Treatment.'
487,979Rank in United States
1,701,884Worldwide Rank
Monthly pages viewed | 9,526 | |
Monthly visits | 4,209 | |
Value per visitor | $2.52 | |
Estimated worth | $3,605 | |
External links | 265 | |
Number of pages | -- |
Last Updated: 04/15/2018 . Estimated data, read disclaimer.
Visitors
Country | Country Rank | Users % | Pageviews % |
United States | 487,979 | 100.00% | 100.00% |
---|
It is most popular in United States.
Traffic History 90 Day Average | ||
Worldwide Rank | 1,430,155 | -224,365 |
---|---|---|
Daily Visitors | 235 | +7% |
Daily Visitors Rank | 1,333,843 | -130,831 |
Daily Pageviews | 300 | +30% |
Daily Pageviews Rank | 1,870,000 | -465,078 |
Pageviews Per User | 1.90 | +20% |
www.Tarceva.com
Topics: Regimen, Considering Tarceva, Possible Benefits Of Tarceva, and How To Take Tarceva.
Category: 'Drugs and Medications/Erlotinib'
Age: The domain is 16 years and 11 months old.
The estimated 257 daily visitors, each view 1.90 pages on average.
Links- Links in
- bioven.com.my Bioven : Your Partner in Fighting Cancer
- nutropinaccesssolution.. Nutropin GPS™ Provider Portal
- ungthu.net Ungthu
- integrateddrugdiscover.. Integrated Drug Discovery | Sygnature
Server Location | |
Genentech Inc. California United States 37.300275, -93.339844 |
Servlet 2.4; JBoss-4.3.0.GA_CP06 (build: is its coding language environment. Its 3 nameservers are dnadns3e.gene.com, dnadns4e.gene.com, and dnadns2e.gene.com. Its web server is located at Genentech Inc. California.
IP: 192.12.78.90
Powered by: Servlet 2.4; JBoss-4.3.0.GA_CP06 (build:
Encoding: iso-8859-1
Website load time is 2795 milliseconds, slower than 72% of other measured websites.
Server Setup | ||
Date: | -- | |
---|---|---|
X-Powered-By: | Servlet 2.4; JBoss-4.3.0.GA_CP06 (build: | SVNTag=JBPAPP_4_3_0_GA_CP06 date=200907141446)/JBossWeb-2.0 |
Set-Cookie: | -- | |
Connection: | close | |
Content-Type: | text/html;charset=ISO-8859-1 | |
Content-Language: | en | |
Set-Cookie: | -- |